TY  - JOUR
T1  - May cyproheptadine be a treatment choice for prophylaxis of PFAPA syndrome?
AU  - Ekici, Arzu
PY  - 2020
DA  - May
Y2  - 2020
DO  - 10.18621/eurj.666806
JF  - The European Research Journal
JO  - Eur Res J
PB  - Prusa Medical Publishing
WT  - DergiPark
SN  - 2149-3189
SP  - 268
EP  - 269
VL  - 6
IS  - 3
LA  - en
AB  - No abstract available.
KW  - PFAPA syndrome
KW  - periodic fever
KW  - aphthous stomatitis
KW  - pharyngitis
KW  - cervical adenitis
CR  - 1. Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome). Acta Paediatr 2010;99:178-84.
CR  - 2. Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr 2013;135:15.
CR  - 3. Stojanov S, Hoffmann F, Kéry A, Renner ED, Hartl D, Lohse P, et al. Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw 2006;17:90-7.
CR  - 4. Müller T, Dürk T, Blumenthal B, Grimm M, Cicko S, Panther E, et al. 5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo. PLoS One 2009;4:e6453.
CR  - 5. Taniguchi K, Ono N, Sakai T, Ichiyama Y, Uemichi K. Response to cimetidine in a 1-year-old child with PFAPA syndrome. Turk J Pediatr 2016;58:687-9.
UR  - https://doi.org/10.18621/eurj.666806
L1  - https://dergipark.org.tr/en/download/article-file/992271
ER  -